Shield Therapeutics Share Discussion Threads

[nobbygnome] 30/7/2019 15:19

Around 45k shares bought since the last sale. Surely this must move up......unless there is a big sell in the wings!

[ny boy] 30/7/2019 15:17

It certainly looks like they are trying to get some cheap stock, the trouble is, very few want to sell now that most of the risk has disappeared and investors are looking forward to the next major event.

Should start to settle in the early 200’s, any dips are rightly being bought by hungry investors, quite often quite difficult to get a fixed quote.

It’s a ray of bright light amongst a generally dull and troubled market.

[crankyman] 30/7/2019 15:12

Missed the boat at 15 p

[1kiwi] 30/7/2019 15:06

Very difficult to buy, I've had to add in small increments but am still a buyer below 220p

[billthebank] 30/7/2019 15:04

Surprised this is closer to 190 rather than 220 but hey no that's life I guess GLAHS

[1kiwi] 30/7/2019 14:47

SING sitting on 198p! ;)

[1kiwi] 30/7/2019 14:46

Business update due to guys and gals!

[nobbygnome] 30/7/2019 14:44

Finncap on the offer at 190p. The next best is 195p!!

[nobbygnome] 30/7/2019 14:39

>> NYB

I do exactly the same. I trade round the edges of all my big investments in order to divert my mind from selling my core holding. I need to keep myself amused.....

[1kiwi] 30/7/2019 14:39

Fill or kill to buy any decent amounts again, will be back over 200p again at this rate

[1kiwi] 30/7/2019 14:38

NY Boy, it's a risky business the old trading game as as soon as the mms get their buy orders filled they raise it like they just have.

[ny boy] 30/7/2019 14:34

In order not to be tempted to sell any of my core holding, my new strategy was to buy some at 182 and trade, sold 199, I have just bought back again and will hold again for another trade, whilst retaining the core holding until the eventual buyout, say with 12/24 months, expecting 400p +

[1kiwi] 30/7/2019 14:30

There it goes, 190p and tight to buy again

[stoneme] 30/7/2019 14:30

Haha - I must have the same problem. MMs are trying to gather sellers at this range. We saw the same yesterday.

[nobbygnome] 30/7/2019 14:28

I feel an afternoon surge coming on..........or is it just my dodgy prostate!

[1kiwi] 30/7/2019 14:10

Look's like a large buy order has been filled, an interesting afternoon folks. What's happening over on the CAD I wonder

[1kiwi] 30/7/2019 14:05

Bid ticked up, 2 vs 1 and fill or kill to buy!

[1kiwi] 30/7/2019 14:04

Order Book Turned!

[stoneme] 30/7/2019 13:36

What's this - 60-100k sells and price stable? If PIs want to offer shares to the MMs at this price to allow them to fill buy orders, who are we to moan. Last week, 5/10k sells moved the price down. This is a buyers market IMO

[crankyman] 30/7/2019 13:21

I think there is still an element of risk as to who they sign up as a partner. If it’s a small outfit like EWO, AOP or Norgine that will focus on the IV end of the market compared to , for example signing up a big player like Pfizer then that’s going to be the difference between 350 and 1000 plus plus

[montyhedge] 30/7/2019 12:23

NY Boy
152% gain here, 153% Jersey Oil, now going into IAG for Friday figures, what a year so far, lol.

[red army] 30/7/2019 12:19

Look like chart is playing out ie testing beak out level for resistance.

[ny boy] 30/7/2019 12:11

Most will hold for the commercialisation deal at least, why sell now, unless you have been in a long time and just knocking a few off but I haven’t seen any major sells, mostly PI’s, add another 100p+ on a deal being announced, so it’s a comfortable hold for me but each to his own, it’s what makes the market.

Catch up tonight

[nobbygnome] 30/7/2019 11:48

Shield got £11 million from Norgine for licensing in Europe and that doesn't include the whole of Europe because Scandinavia and Switzerland are licensed to other companies. Since that deal was done the outlook has improved because of the increased in market safety data, the clinical results from the non inferiority study and the wider label. So the fact that the US is a much bigger market and the factors which have improved since that deal means that for me $50 million is achievable.

That doesn't mean they will get that much because there are multiple ways to structure a deal. They really don't need loads of cash at this time so perhaps they will go for a relatively low upfront sum but higher royalties than in the Norgine deal. Whatever they choose, the commercial future for Feraccru and hence STX look remarkably good. The company is definitely undervalued at £200 million but clearly we need to see the confirmation of a deal and the actual commercial terms to really get a true view.